Compare Cytokinetics Inc (CYTK) vs HCA Health Inc (HCA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs HCA Health Inc — how do they compare? Cytokinetics Inc trades at $76.67 (market cap $10.63B), while HCA Health Inc trades at $411.49 (market cap $89.08B). The key difference: HCA Health Inc is far larger — about 8.4× Cytokinetics Inc's market cap, and HCA Health Inc pays a 0.76% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.
| CYTK | HCA | |
|---|---|---|
Market Cap | $10.63B | $89.08B |
Sector | Technology | Health |
52-Week High | $87.26 | $545.13 |
52-Week Low | $34.31 | $361.32 |
Enterprise Value | $10.74B | $139.62B |
Dividend Yield | — | 0.76% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →
